Paxmedica, Inc. [PXMD]

Source: 

Company Overview

Paxmedica, Inc. is a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder, to neurodegenerative disorders such as Fragile X Tremor Ataxia Syndrome and post-viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, which causes physical and cognitive decline in affected adults.